Prostate Cancer Drug Pipeline Update 2016 – Research and Markets

Prostate Cancer Drug Pipeline Update 2016 – Research and Markets

There are today 450 companies plus partners developing 453 drugs targeting prostate cancer in development. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 228 drugs. Prostate …

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.